1/11
03:57 am
crmd
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
Medium
Report
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) [Seeking Alpha]
1/9
10:54 am
crmd
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
Medium
Report
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge [Seeking Alpha]
1/9
08:30 am
crmd
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/9
08:02 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $15.00. They now have a "buy" rating on the stock.
1/9
04:31 am
crmd
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
Low
Report
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story [Yahoo! Finance]
1/8
04:38 pm
crmd
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
Low
Report
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes [Yahoo! Finance]
1/8
03:03 pm
crmd
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
Low
Report
CorMedix (NASDAQ:CRMD) was given a new $16.00 price target on by analysts at Truist Financial Corporation.
1/8
02:48 pm
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
1/8
08:17 am
crmd
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]
High
Report
CorMedix Therapeutics Announces Leadership and Board Updates [Yahoo! Finance]
1/8
08:05 am
crmd
CorMedix Therapeutics Announces Leadership and Board Updates
High
Report
CorMedix Therapeutics Announces Leadership and Board Updates
1/8
08:00 am
crmd
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
High
Report
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
12/26
10:35 am
crmd
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? [Yahoo! Finance]
Low
Report
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? [Yahoo! Finance]
12/25
07:32 am
crmd
CorMedix (CRMD): Assessing Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]
Medium
Report
CorMedix (CRMD): Assessing Valuation After a Strong Multi-Year Share Price Run [Yahoo! Finance]
12/19
02:44 pm
crmd
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]
Low
Report
Is It Too Late to Consider CorMedix After DefenCath Progress and Strong Price Gains? [Yahoo! Finance]
12/18
03:25 pm
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
12/18
08:00 am
crmd
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
Medium
Report
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
12/16
09:02 am
crmd
5 High Earnings Yield Value Picks Ahead of Key Economic Reports [Yahoo! Finance]
Low
Report
5 High Earnings Yield Value Picks Ahead of Key Economic Reports [Yahoo! Finance]
11/24
07:25 pm
crmd
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? [Yahoo! Finance]
Medium
Report
Assessing CorMedix (CRMD): Is the Current Share Price Reflecting Its True Value? [Yahoo! Finance]
11/20
08:10 pm
crmd
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... [Yahoo! Finance]
Low
Report
Cormedix Inc (CRMD) Q3 2025 Earnings Call Highlights: Record Financial Performance and ... [Yahoo! Finance]
11/18
07:06 pm
crmd
Does the Recent 9.9% Pullback Make CorMedix a Bargain in 2025? [Yahoo! Finance]
Low
Report
Does the Recent 9.9% Pullback Make CorMedix a Bargain in 2025? [Yahoo! Finance]
11/18
06:38 am
crmd
Buy Rating Reaffirmed: CorMedix Inc. (CRMD) Posts Profitability and Expands Outlook for 2025 [Yahoo! Finance]
Low
Report
Buy Rating Reaffirmed: CorMedix Inc. (CRMD) Posts Profitability and Expands Outlook for 2025 [Yahoo! Finance]
11/18
05:22 am
crmd
H.C. Wainwright Raises the PT on ?CorMedix Inc. (CRMD), Keeps a Buy [Yahoo! Finance]
Low
Report
H.C. Wainwright Raises the PT on ?CorMedix Inc. (CRMD), Keeps a Buy [Yahoo! Finance]
11/14
02:57 pm
crmd
CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating [Seeking Alpha]
Low
Report
CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating [Seeking Alpha]
11/13
08:11 am
crmd
CorMedix (NASDAQ:CRMD) had its price target raised by analysts at HC Wainwright from $17.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target raised by analysts at HC Wainwright from $17.00 to $18.00. They now have a "buy" rating on the stock.
11/12
07:14 pm
crmd
Talphera signals study completion in first half of 2026 as new site activations delay NEPHRO timeline [Seeking Alpha]
Low
Report
Talphera signals study completion in first half of 2026 as new site activations delay NEPHRO timeline [Seeking Alpha]